Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinghua Weikang capsules
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jinghua Weikang capsules (also known as Jinghua Weikang) is a Chinese patent medicine (traditional Chinese medicine) developed by Tasly Pharmaceutical Group. It is composed of extracts from *Dysphania ambrosioides* (formerly *Chenopodium ambrosioides*) and *Adina pilulifera* in a rapeseed oil vehicle. Jinghua Weikang is approved in China for the treatment of peptic ulcers (including gastric, duodenal, and esophageal ulcers) and chronic gastritis, and is widely used as an adjuvant therapy to assist in the eradication of *Helicobacter pylori* infections. The formulation exhibits multi-target therapeutic effects, including direct bactericidal activity against antibiotic-resistant *H. pylori* strains, inhibition of gastrointestinal smooth muscle contraction, reduction of gastric acid secretion and pepsin activity, and promotion of gastric mucosal protection and healing.
- Brand names
- Jinghua Weikang
- Other names
- JWCJinghua Weikang CapsuleJinghua Weikang capsulesJinghuaweikangJinghuaweikang capsuleJinghuaweikang capsules
02
Targets
HP-NAP (Helicobacter pylori neutrophil-activating protein)HA (Hemagglutinin)
Beyond the preview
Go deeper on Jinghua Weikang capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinghua Weikang capsules.